ClinicalTrials.gg
RecruitingNCT05761678e-QoL-TransUpdated Mar 9, 2023

Quality of Life of Transgender People - Implementation and Monitoring of an Online Cohort (e-QoL-Trans)

An observational study in Transgenderism and Gender Identity, sponsored by Ramsay Générale de Santé. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-09.

Sponsored by Ramsay Générale de Santé · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Study summary

Transgender people have an identity or an expression gender that differs from the sex assigned to them at the birth. Transgender people and their needs remain misunderstood, and more generally by society. THE transgender populations express poor quality of life compared to the general population. However, very few of studies are interested in these people, in their diversity of paths, trajectories and characteristics of life. More of research is needed to study the quality of life, understand the experiences, in their diversity and in the health, social and life trajectories. Researches must be carried out, in particular on how to interrogate by the seeks out transgender people, in order to prevent stigmatization within population studies.

The main objective of this study is to assess the quality of life of people transgender people during their life trajectory and their transition path, based on validated questionnaires scientifically in French, for major themes of the population concerned (quality of life, social support perceived).

02

Conditions studied

  • Transgenderism
  • Gender Identity

Browse trials for

03

In context

Transsexualism

54 studies on the registry are indexed under Transsexualism; 18 are open to participants now.

This study's planned enrollment of 500 is above the median of 100 across 28 observational studies indexed under Transsexualism.

Browse Transsexualism studies →

Lead sponsor

Ramsay Générale de Santé is the lead sponsor of 42 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Transgender people, whether they have transitioned or not, with or without reassignment surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Transgender people (having a gender identity or expression that differs from the sex assigned to them at birth);
  • People with any of the following characteristics regarding their trans identity:

    • Consultant in one of the transgender reference centers and services for questions/information on the transition;
    • Integrated or having completed a course of care with or without gender reassignment surgery;
    • Not integrated into a health or care pathway.
  • French-speaking people;
  • Adults;
  • People able to use the tools digital;
  • People with Internet or 4G access (total or limited)

Exclusion criteria

Exclusion Criteria:

  • People who do not identify as transgender;
  • Non-French speaking people;
  • Minors
  • People who do not know how to handle the tools digital data collection;
  • People without Internet access.
  • Non-French speaking people, unable to speak understand the research questions
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administrative
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Transgender people

    Whether they have transitioned or not, with or without reassignment surgery.

    Other: Questionnaire quality of life

Interventions

  • OtherQuestionnaire quality of life

    Quantitative - Validated online self-questionnaires scientifically to assess quality of life and support perceived social. Items created for the study concerning socio-demographic characteristics and satisfaction of health services concerning the accompaniment of the transidentity. Qualitative - Semi-structured interviews based on a guide maintenance.

06

What researchers measure

Primary outcomes

  1. Quality of life estimated with a validated questionnaire administered over the Internet repeatedly every three months.

    Quality of life estimated with a validated questionnaire administered over the Internet repeatedly every three months.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2023 (actual). Primary completion is estimated for Aug 2025, 30 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2023
First posted
Mar 9, 2023
StartActual
Feb 21, 2023
Primary completionEst.
Aug 21, 2025
CompletionEst.
Feb 21, 2026
Last update
Mar 9, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05761678
Lead sponsor
Ramsay Générale de Santé
Responsible party
Sponsor
First posted
Mar 9, 2023
Start date
Feb 21, 2023
Primary completion
Aug 21, 2025 (estimated)
Completion
Feb 21, 2026 (estimated)
Last update
Mar 9, 2023

Study contacts

Jean-François Oudet
Contact
jf.oudet@ecten.eu
0683346567

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion